EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States

Trisha L Amboree iD, Poria Dorali iD, Haluk Damgacioglu iD, Jane R Montealegre, Marvella E Ford iD, Brian Orr iD, Gweneth Lazenby iD, Britton Gibson iD, Ana P Ortiz iD, Tonatiuh Suárez Ramos iD, Kalyani Sonawane iD, Ashish A Deshmukh iD

JNCI Cancer Spectrum · 09.01.2026 · 10 (1)

DOI: 10.1093/jncics/pkag005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 25.01.2026. Verfasst von Trisha L Amboree und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Hollings Cancer Center, MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer elimination (<4 cases per 100 000) is a critical cancer prevention goal in the United States. Implementation of health policies and allocation of health resources occur at regional and state levels; therefore, understanding region- and state-specific cervical cancer incidence, mortality, and progress toward elimination—and remaining gaps—is essential. We estimated hysterectomy-corrected cervical cancer incidence, mortality, and progress toward elimination across all 50 states, the District of Columbia, and Puerto Rico. In 2021, Massachusetts was the only state nearing (4.3 per 100 000) the elimination threshold. Southeastern and Southwestern states were furthest, with the highest incidence rates in Mississippi (14.8), Louisiana (14.2), and Oklahoma (13.8). The mortality rate ranged from 6.8 (Alabama) to 1.4 (Wisconsin). In most states, cervical cancer incidence and mortality did not change from 2007-2011 to 2017-2021. Identifying and addressing regional- and state-level barriers impeding progress will be key to achieving cervical cancer elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsFemaleHumansIncidenceUnited StatesHysterectomy

Autor:innen und Institutionen

  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.
  • Cancer Prevention and Control Program, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
  • Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Division of Gynecologic Oncology, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, United States.
  • Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, United States.
  • Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, PR, United States.

ORCID-Profile: Trisha L Amboree, Poria Dorali, Haluk Damgacioglu, Marvella E Ford, Brian Orr, Gweneth Lazenby, Britton Gibson, Ana P Ortiz, Tonatiuh Suárez Ramos, Kalyani Sonawane, Ashish A Deshmukh

Förderung

  • NCI NIH HHS
  • Hollings Cancer Center
  • MD Anderson Cancer Center
  • NLM NIH HHS
  • American Cancer Society Institutional Research Grant
  • National Cancer Institute
  • National Library of Medicine

Zitieren

APA

Amboree, T. L., Dorali, P., Damgacioglu, H., Montealegre, J. R., Ford, M. E., Orr, B., Lazenby, G., Gibson, B., Ortiz, A. P., Suárez Ramos, T., Sonawane, K., & Deshmukh, A. A. (2026). The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States. JNCI Cancer Spectrum, 10(1). https://doi.org/10.1093/jncics/pkag005

Vancouver

Amboree TL, Dorali P, Damgacioglu H, Montealegre JR, Ford ME, Orr B, et al. The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States. JNCI Cancer Spectrum. 2026;10(1). doi:10.1093/jncics/pkag005

BibTeX
@article{Amboree2026,
  author = {Amboree, Trisha L and Dorali, Poria and Damgacioglu, Haluk and Montealegre, Jane R and Ford, Marvella E and Orr, Brian and Lazenby, Gweneth and Gibson, Britton and Ortiz, Ana P and Suárez Ramos, Tonatiuh and Sonawane, Kalyani and Deshmukh, Ashish A},
  title = {The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  volume = {10},
  number = {1},
  doi = {10.1093/jncics/pkag005}
}
Kostenlos starten →